SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-168285
Filing Date
2022-06-06
Accepted
2022-06-06 15:45:02
Documents
12
Period of Report
2022-06-02
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d274679d8k.htm   iXBRL 8-K 38941
  Complete submission text file 0001193125-22-168285.txt   161195

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pmvp-20220602.xsd EX-101.SCH 2851
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmvp-20220602_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmvp-20220602_pre.xml EX-101.PRE 11258
6 EXTRACTED XBRL INSTANCE DOCUMENT d274679d8k_htm.xml XML 3349
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39539 | Film No.: 22997964
SIC: 2834 Pharmaceutical Preparations